EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 17:15 ET (22-Jun-2026 21:15 GMT/UTC)

MSK Research Highlights, March 27, 2026

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

New research from Memorial Sloan Kettering Cancer Center (MSK) finds skin stem cells retain long-lasting memory of inflammation; shows how a large cancer DNA study could transform personalized oncology; reveals how the protein BAF helps cancer cells hide from the immune system; and investigates how early DNA markings shape cell fate.

Molecular test doubles detection of bile duct cancer

University of Pittsburgh
Peer-Reviewed Publication

Scientists at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine developed BiliSeq, a molecular test that detected bile duct cancer with twice the sensitivity of the standard test, giving physicians a more accurate picture of the patient’s diagnosis.

Journal: Gastroenterology
Funder: National Pancreas Foundation, Sky Foundation, Pancreatic Cancer Action Network

Damon Runyon scientists gather for 2026 Accelerating Cancer Cures Symposium

Damon Runyon Cancer Research Foundation
Meeting Announcement

Damon Runyon scientists and industry partners gathered on Tuesday, March 24, for the 2026 Accelerating Cancer Cures Research Symposium, hosted by Amgen in Cambridge, Massachusetts.

Simple tumor biomarker test predicts which stomach cancer patients will respond to immunotherapy

Science China Press
Peer-Reviewed Publication

Chinese researchers identified tumor-specific MHC-II (tsMHC-II) expression as a novel biomarker predicting response to neoadjuvant immunotherapy in gastric cancer. Single-cell profiling revealed higher MHC-II expression in tumor cells from treatment-sensitive patients. Validated in prospective trials, tsMHC-II-positive patients achieved 36.67% pathological complete response rate versus low rates in unselected populations. This simple immunohistochemistry-based biomarker outperforms current PD-L1 assessment and could guide personalized therapy for gastric cancer patients.

Journal: Science Bulletin

Emerging light-powered cancer treatment gets a nanotech upgrade

Higher Education Press
Peer-Reviewed Publication

This article explores recent advances in liposomal nanotechnology for photodynamic therapy, showing how improved drug loading, targeting, and light-activated efficiency are enhancing cancer treatment outcomes.

Journal: Frontiers of Optoelectronics

Snail inspired soft robots to transform precision drug delivery in bowel cancer

University of Manchester
Grant and Award Announcement

Manchester researchers have secured nearly £1 million from UKRI to develop miniature snail inspired soft robots capable of delivering anti cancer drugs with unprecedented precision inside the human body.

Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows in China

European Society for Medical Oncology
Reports and Proceedings

New evidence from a Chinese cohort presented today at the European Lung Cancer Congress (ELCC) 2026 shows that onetime lowdose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a non–risk based population, including individuals with no smoking history.

Boron neutron capture therapy: a new hope for cancer treatment

Research
Peer-Reviewed Publication

Malignant gliomas are among the deadliest brain cancers, with limited treatment options and poor survival. A new comprehensive review analyzes decades of global clinical data on boron neutron capture therapy (BNCT), a targeted radiation approach. The study finds consistent survival benefits across multiple tumor types and treatment settings. By synthesizing evidence from accelerator- and reactor-based studies worldwide, the work highlights BNCT's renewed clinical promise and outlines key challenges for broader adoption.

Journal: Research
Funder: National Nature Science Foundation of China, Guangdong Province Basic and Applied Basic Research Fund Special Project (Regional Cultivation Project), Guangdong Province Basic and Applied Basic Research Fund Special Project (Regional Joint Fund-Key Project), Open Fund of the China Spallation Neutron Source Songshan Lake Scientific City

Early results from a trial of active surveillance for low-risk DCIS are ‘reassuring’

European Organisation for Research and Treatment of Cancer
Reports and Proceedings

Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as ‘reassuring’ in a presentation to the 15^th European Breast Cancer Conference.

Meeting: 15th European Breast Cancer Conference

Tumor DNA circulating in patients’ blood after pre-surgery treatments predicts whether breast cancer will return

European Organisation for Research and Treatment of Cancer
Reports and Proceedings

Fragments of tumour DNA circulating in the bloodstream of patients with breast cancer can predict whether they are likely to relapse, especially when samples are taken after the patients have received treatments prior to surgery. The study, presented at the 15^th European Breast Cancer Conference (EBCC15) in Barcelona, included the largest number of events reported so far for circulating tumour DNA (ctDNA) in individual patients.

Funder: La Fondation Contre le Cancer, Les Amis de l'Institut Bordet, 5x1000 del Ministero della Salute
Meeting: 15th European Breast Cancer Conference